We provide precision profiling of tissue-specific markers including CD133, CD44, and EpCAM using multi-parametric flow cytometry to accurately quantify and isolate stem-like fractions from complex tissues.
Learn More →Cancer Stem Cell Biomarker & Subtyping Research Services
Creative Biolabs provides a robust analytical platform for the identification and characterization of cancer stem cells (CSCs) within complex tumor populations. Our service delivers high-purity isolation of stem-like subpopulations, detailed molecular subtyping, and functional assessment of self-renewal capacity under niche-mimicking conditions. Clients gain high-resolution transcriptomic maps and validated biomarker signatures, enabling the identification of novel drug targets and the assessment of compound efficacy against the most resistant cellular fractions. By partnering with us, researchers gain access to the precise biological data necessary to understand clonal evolution and overcome resistance mechanisms in preclinical drug development.
Introduction What We Can Offer Types of Our Services Why Choose Us? Customer Reviews FAQs Related Services Contact Us
Why do CSC Research
Cancer stem cells represent a subpopulation within tumors capable of self-renewal, differentiation, and experimental resistance. Emerging research confirms that CSCs utilize iPSC-like reprogramming factors to maintain plasticity. Our service is built upon these scientific findings, providing the tools to analyze how driver mutations and the tumor microenvironment (TME) contribute to the stabilization of these factors. By targeting CSCs, we address the fundamental biological cause of experimental metastasis and tumor progression.
For an in-depth analysis of how our services can be tailored to your specific project needs, request a consultation.
Fig.1 Potential lung cancer stem cell with its markers and major signaling pathways. 1
What We Can Offer
End-to-End CSC Workflow
We offer a seamless, one-stop research service spanning primary tissue dissociation and stem-like cell enrichment to large-scale functional validation and experimental drug sensitivity testing in specialized models.
Customized Panel Design
Our experts optimize sophisticated multi-color flow cytometry and transcriptomic panels, specifically tailored to resolve the unique molecular signatures of your chosen tumor models and target indications.
Advanced Niche Simulation
We utilize specialized 3D culture platforms and precise hypoxia chambers to maintain the physiological "stemness" and metabolic profiles of samples during experiments.
High-Resolution Subpopulation Mapping
We identify minor but biologically significant CSC clones, such as CD13-positive or ABCB5-positive cells, which are typically obscured or completely missed by standard bulk analysis.
Types of our Cancer Stem Cell Biomarker & Subtyping Research Services
Cancer Stem Cell Surface Marker Detection Service
Cancer Stem Cell vs. Non-Cancer Stem Cell Gene Expression Profiling Service
This service utilizes comparative transcriptomics to identify unique survival nodes and signaling pathways in stem-like fractions, highlighting the molecular differences that drive tumor persistence and recurrence.
Learn More →Single-Cell RNA-Seq Cancer Stem Cell Subpopulation Analysis Service
We resolve the extreme heterogeneity within the CSC pool at single-cell resolution, identifying the most aggressive subclones and tracking their evolutionary trajectory during experimental therapy resistance.
Learn More →Cancer Stem Cell Immune Checkpoint Molecule Detection Service
Our team analyzes PD-L1 and other critical evasion markers specifically on the CSC surface in research models to understand how these cells bypass biological surveillance mechanisms.
Learn More →Cancer Stem Cell Antigen Processing & Presentation Molecule Analysis Service
We evaluate MHC-I expression and other antigen processing molecules in stem cells to identify vulnerabilities in the biological evasion mechanisms utilized by resistant cancer cell populations.
Learn More →Cancer Stem Cell Plasticity & Differentiation Assay Service
We perform functional assessments of the epithelial-mesenchymal transition and the inherent capacity of isolated cells to regenerate a complete tumor mass within specialized 3D culture environments.
Learn More →Cancer Stem Cell Side Population (SP) Dye Exclusion Detection Service
This assay utilizes Hoechst 33342 efflux to identify CSCs based on ABC transporter activity, providing a functional measurement of the cells' biological drug-efflux and resistance capabilities.
Learn More →Why Choose Us?
Physiological Niche Accuracy
Our unique modeling capabilities focus on the complex tumor microenvironment, delivering experimental data that accurately reflects biological resistance mechanisms rather than relying on oversimplified or standard cell culture results.
Rigorous Scientific Benchmarking
Every laboratory assay we perform is meticulously benchmarked against validated published data, ensuring your research findings meet the high standards required for peer-reviewed publications and advanced preclinical development.
Advanced Characterization Tools
We employ high-resolution mapping and multi-omic integration to resolve cellular hierarchies, allowing researchers to track clonal evolution and target the most resilient subpopulations within their specific tumor models.
To fully understand the Creative Biolabs advantage, we invite you to get a quote today.
Customer Reviews
-
Precision Subtyping Mastery
Using Creative Biolabs' CSC Subtyping in our breast cancer research has facilitated the identification of CD44-positive/CD24-low populations that were previously masked by bulk RNA-seq. The clarity in their reporting is unmatched. - Dr. M**r. S. -
Exceptional Hypoxia Modeling
The ability to simulate the hypoxic niche in our glioblastoma models significantly improved our understanding of HIF-2 alpha stabilization. Creative Biolabs' protocols for maintaining CSC stemness are truly superior. - Prof. R**b. L.
FAQs
How do you prevent CSCs from differentiating during the study?
We utilize specialized serum-free media and growth factor cocktails like EGF and bFGF, which are meticulously optimized to maintain the undifferentiated, pluripotent state throughout the entire duration of the laboratory assay.
Can you perform these services on FFPE research samples?
While flow cytometry requires fresh biological tissue for viability, we offer advanced RNAscope and spatial transcriptomics for FFPE samples to precisely map CSC biomarkers and their spatial distribution in situ.
Related Services
Targeting Tumor Microenvironment Services
We offer comprehensive profiling of the TME, analyzing complex interactions between malignant cells, immune infiltrates, and the extracellular matrix to identify novel therapeutic targets and biological resistance pathways.
Learn More →Cancer Cell Engineering Strategies
We provide advanced genetic engineering strategies to modify cancer cells for therapeutic research, including the development of specialized cell lines with enhanced immunogenicity or targeted delivery capabilities for immuno-oncology.
Learn More →How to Contact Us
Creative Biolabs provides a complete ecosystem for CSC research, from initial biomarker identification to high-throughput functional screening. Our services are designed to advance basic stem cell biology and preclinical oncology drug discovery. For detailed project discussions or to receive a customized quote, please reach out to our team.
Reference
- Zheng, Yue et al. "Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies." Frontiers in oncology vol. 12 873994. 26 May. 2022. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fonc.2022.873994
Download our brochureLoading case studies...
Online Inquiry